79.7
Actinium Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
111
FY23:
78.3
FY24:
74.5
FY25:
49.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.64
FY22:
3.25
FY23:
3.18
FY24:
2.39
FY25:
2.39
Total assets
Change from FY21 to FY25
millions USD
FY21:
80.4
FY22:
114
FY23:
81.4
FY24:
76.9
FY25:
51.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.84
FY22:
10.6
FY23:
8.49
FY24:
8.15
FY25:
7.97
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.00
FY22:
37.1
FY23:
36.6
FY24:
36.0
FY25:
36.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
73.5
FY22:
66.5
FY23:
36.4
FY24:
32.8
FY25:
7.83
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
80.4
FY22:
114
FY23:
81.4
FY24:
76.9
FY25:
51.8
All amounts in millions USD